| Dr Richard Mann, MD | |
|
1850 W Arlington Blvd, Greenville, NC 27834-5704 | |
| (252) 752-6101 | |
| (252) 752-6600 |
| Full Name | Dr Richard Mann |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1850 W Arlington Blvd, Greenville, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053314062 | NPI | - | NPPES |
| 8953866 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 27878 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Mann, MD 1850 W Arlington Blvd, Greenville, NC 27834-5704 Ph: (252) 752-6101 | Dr Richard Mann, MD 1850 W Arlington Blvd, Greenville, NC 27834-5704 Ph: (252) 752-6101 |
News Archive
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the enrollment and completed dosing of the first XLHED-affected neonate in a Phase 2 trial of EDI200, the company's novel, proprietary, recombinant protein.
In the meantime, some sparring continues over the law, a new poll looks at Americans' attitudes on Obamacare, and Democrats continue their push to try to drum up support for the overhaul.
Patients with obstructive sleep apnea (OSA) may blame their daytime difficulties on simple sleepiness, but new research suggests that their brains may be to blame. Specifically, their cognitive challenges may be caused by structural deficits in gray matter, brought on by the intermittent oxygen deprivation that comes with OSA. The good news is that these deficits may be partially or fully reversible with early detection and treatment, according to Italian researchers
Cell Therapeutics, Inc. (CTI) today announced that the Gynecologic Oncology Group (GOG) informed CTI that an independent Data Safety Monitoring Board (DSMB) recommended continuation of the GOG-0212 Phase 3 clinical trial of OPAXIOTM (paclitaxel poliglumex) as maintenance therapy in ovarian cancer with no changes following a planned interim survival analysis.
› Verified 2 days ago
Dr. John N Catanzaro, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 115 Heart Dr, Greenville, NC 27834 Phone: 252-744-4400 Fax: 252-744-3987 | |
Ms. Kimberly Michelle Biichle, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1400 Sullivan Dr, Greenville, NC 27834 Phone: 252-931-5686 | |
Jennifer Beth Emberger, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2390 Hemby Ln, Greenville, NC 27834 Phone: 252-744-4500 Fax: 252-744-5713 | |
Dr. Edward L Treadwell, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 600 Moye Blvd, Greenville, NC 27834 Phone: 252-744-3169 Fax: 252-744-3725 | |
Dr. Alpesh Patel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2210 Hemby Ln, Greenville, NC 27834 Phone: 252-551-3000 Fax: 252-551-3100 | |
Dr. Kara Anne Regan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 521 Moye Blvd Ste C3, Greenville, NC 27834 Phone: 252-816-0800 | |
Radhamani Kannaiyan, M.D., Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2100 Stantonsburg Rd, Greenville, NC 27834 Phone: 520-548-7894 |